← Back
Data updated: Mar 10, 2026
NE RX PHARMA
CardiovascularGastroenterologyNeurology
NE RX PHARMA is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Neurology.
2022
Since
5
Drugs
-
Trials
35
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ACETAZOLAMIDE 2026-01-12
Labeling
VARENICLINE TARTRATE 2026-01-09
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
METOLAZONE 2026-01-07
Manufacturing (CMC)
VARENICLINE TARTRATE 2025-12-18
Labeling
ACETAZOLAMIDE 2025-11-25
Manufacturing (CMC)
VARENICLINE TARTRATE 2025-10-29
VARENICLINE TARTRATE 2025-09-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 40%
2 drugs
Gastroenterology 20%
1 drugs
Neurology 20%
1 drugs
Ophthalmology 20%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
BAUSCH specialty
Ophthalmology, Cardiovascular, Gastroenterology
Novartis big-pharma
Cardiovascular, Ophthalmology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Ophthalmology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology
Active (5)
Discontinued (0)
Company Info
- First Approval
- 2022-08-16
- Latest
- 2025-09-24
- Applications
- 5